EYE On Stakeholders: MAX India Group Sells Various Firms To PE Players.
M & A Critique|April 2019

Max India sold its entire 51% stake in Max Bupa Health Insurance Co Ltd to private equity firm True North Fund for over Rs 510 crore.

Padam Singh
EYE On Stakeholders: MAX India Group Sells Various Firms To PE Players.

Earlier, it was in talks with HDFC Life to merger its life insurance business Max Life. But that failed as the insurance regulator objected to the proposed deal.

Existing Group Structure:

In fact, Max Bupa's divestment follows Analjit Singh-owned company's composite transaction involving demerger of Max India and the merger of Max Healthcare with Radiant-KKR. In the business community, savy Analjit Singh is known as a serial entrepreneur, who builds and sells his businessess. He has the ability to spot an opportunity in business like he did with telecom where he made Rs 561 crore in 1998 by selling his 41% stake in a joint venture with Hutchison Whampoa Ltd and insurance and healthcare early on, and more than that to quit when the business is on the top.

Proposed Transaction:

In a move to separate its Healthcare Business from other businesses, MIL will;

STEP I: Demerged its “Allied Health and Associated Activities” into Advaita appointed date is Feb. 1, 2019.

Max India Ltd. (MIL)

is a listed company engaged in business of health and allied businesses. It holds stake in Max Healthcare, Max Bupa Health Insurance and Antara Senior Living. Max Healthcare and Max Bupa Health Insurance are joint ventures with global leaders Life Healthcare (South Africa) and Bupa Finance Plc. (UK), respectively. The Company owns 49.70% in Max Healthcare, a 51% in Max Bupa Health Insurance and a 100% in Antara Senior Living.

Max Healthcare Institute Ltd.(MHIL)

Denne historien er fra April 2019-utgaven av M & A Critique.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra April 2019-utgaven av M & A Critique.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA M & A CRITIQUESe alt
Raymond Group continues Segregation of its Business Verticals
M & A Critique

Raymond Group continues Segregation of its Business Verticals

After successful demerger of \"Lifestyle Business,\" Raymond Limited announced yet another restructuring to unlock further value for stakeholders.

time-read
3 mins  |
August 2024
Ultratech Cements adds India Cement in its shopping cart
M & A Critique

Ultratech Cements adds India Cement in its shopping cart

India's Cement Industry is poised for consolidation. In recent past we have seen multiple large & small acquisitions in cement segment for consolidating positions.

time-read
3 mins  |
August 2024
Valor Estate Limited: "Diversification" to "Sepration" of Hospitality Business
M & A Critique

Valor Estate Limited: "Diversification" to "Sepration" of Hospitality Business

“From investments in hospitality business, the demerger transaction will enable VEL to start its construction in hospitality”

time-read
4 mins  |
August 2024
SIEMENS Energy to be a separate entity in alignment with global strategy
M & A Critique

SIEMENS Energy to be a separate entity in alignment with global strategy

Siemens AG announced its Vision 2020+ which included the spin-off of its Gas & Power [G&P) i.e., Energy Business into Siemens Energy.

time-read
5 mins  |
June 2024
Arvind Group separates its Advanced Material Business for independent growth trajectory
M & A Critique

Arvind Group separates its Advanced Material Business for independent growth trajectory

Advanced Material Business (AMD) of Arvind Limited focuses on advanced materials and caters to customer needs across the textile value chain, including specialty yarns, fabrics, and ready-made products.

time-read
3 mins  |
June 2024
Merger for bail-out from debt obligation
M & A Critique

Merger for bail-out from debt obligation

Ind Swift Limited (herein after also referred to as 'ISL' or 'Transferor Company') is engaged in the business of manufacturing of Pharmaceutical Products.

time-read
3 mins  |
June 2024
Batliboi Ltd. merging its associate company
M & A Critique

Batliboi Ltd. merging its associate company

Batliboi Limited has a history of collaborations with various foreign technical partners and has subsidiaries like Hydraulic & General Engineers Ltd. and Batliboi International Ltd. In March 2024, the board of Directors of Batliboi Limited accorded their approval for the merger of promoter owned private company with itself.

time-read
2 mins  |
May 2024
TVS Motors issuances of convertible preference shares as bonus instead of dividend
M & A Critique

TVS Motors issuances of convertible preference shares as bonus instead of dividend

Recently, well known auto manufacturer announced the issuance of preference shares as a bonus to all equity shareholders.

time-read
3 mins  |
May 2024
Aditya Birla Fashion & Retails Scheme to undo its consolidation
M & A Critique

Aditya Birla Fashion & Retails Scheme to undo its consolidation

Corporate restructuring saga continues for Aditya Birla Group.

time-read
5 mins  |
May 2024
Advent International to combine its listed & private entity business
M & A Critique

Advent International to combine its listed & private entity business

Recently, Advent International announced the merger of its privately held pharma company into recently acquired listed pharma company.

time-read
6 mins  |
April 2024